Abbott Laboratories (ABT) Return on Capital Employed (2009 - 2026)
Abbott Laboratories recorded quarterly Return on Capital Employed of 9.61% in Q1 2026, down 17.74% quarter-over-quarter from 11.68% in Q4 2025, and down 81.0% year-over-year from 50.57% in Q1 2025.
Abbott Laboratories' Return on Capital Employed history runs 18 years deep, the most recent figure standing at 9.61% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 81.0% year-over-year to 9.61%; the TTM figure through Mar 2026 stood at 9.61% (down 81.0% YoY), while the FY2025 annual figure was 11.92%, up 111.0% from the prior year.
- Return on Capital Employed came in at 9.61% for Q1 2026 at Abbott Laboratories, down from 11.68% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 37.41% in Q4 2022 to a low of 9.61% in Q1 2026.
- A 5-year average of 15.34% and a median of 11.01% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed jumped 669 bps in 2022 and slumped 2639 bps in 2023, its largest moves.
- Abbott Laboratories' Return on Capital Employed stood at 37.41% in 2022, then slumped by 71 bps to 11.01% in 2023, then retreated by 3 bps to 10.71% in 2024, then advanced by 9 bps to 11.68% in 2025, then dropped by 18 bps to 9.61% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 9.61%, 11.68%, and 11.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.61% |
| Dec 31, 2025 | 11.68% |
| Sep 30, 2025 | 11.10% |
| Jun 30, 2025 | 10.85% |
| Mar 31, 2025 | 10.42% |
| Dec 31, 2024 | 10.71% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | 10.99% |
| Mar 31, 2024 | 10.80% |
| Dec 31, 2023 | 11.01% |
| Sep 30, 2023 | 10.06% |
| Jun 30, 2023 | 10.34% |
| Mar 31, 2023 | 29.23% |
| Dec 31, 2022 | 37.41% |
| Sep 30, 2022 | 15.69% |
| Jun 30, 2022 | 16.55% |
| Mar 31, 2022 | 32.97% |
| Dec 31, 2021 | 30.72% |
| Sep 30, 2021 | 13.98% |
| Jun 30, 2021 | 12.30% |
| Mar 31, 2021 | 26.44% |
| Dec 31, 2020 | 22.27% |
| Sep 30, 2020 | 7.36% |
| Jun 30, 2020 | 7.07% |
| Mar 31, 2020 | 18.06% |
| Dec 31, 2019 | 17.41% |
| Sep 30, 2019 | 7.43% |
| Jun 30, 2019 | 6.96% |
| Mar 31, 2019 | 6.49% |
| Dec 31, 2018 | 6.04% |
| Sep 30, 2018 | 5.48% |
| Jun 30, 2018 | 4.79% |
| Mar 31, 2018 | 3.74% |
| Dec 31, 2017 | 2.39% |
| Sep 30, 2017 | 2.67% |
| Jun 30, 2017 | 2.85% |
| Mar 31, 2017 | 4.10% |
| Dec 31, 2016 | 7.68% |
| Sep 30, 2016 | 9.74% |
| Jun 30, 2016 | 9.23% |
| Mar 31, 2016 | 8.68% |
| Dec 31, 2015 | 8.88% |
| Sep 30, 2015 | 8.43% |
| Jun 30, 2015 | 8.41% |
| Mar 31, 2015 | 8.63% |
| Dec 31, 2014 | 8.28% |
| Sep 30, 2014 | 7.69% |
| Jun 30, 2014 | 6.76% |
| Mar 31, 2014 | 6.52% |
| Dec 31, 2013 | 6.89% |
| Sep 30, 2013 | 5.26% |
| Jun 30, 2013 | 4.80% |
| Mar 31, 2013 | 3.29% |
| Dec 31, 2012 | 2.62% |
| Sep 30, 2012 | -1.42% |
| Jun 30, 2012 | -0.83% |
| Mar 31, 2012 | 1.88% |
| Dec 31, 2011 | 3.66% |
| Sep 30, 2011 | 12.11% |
| Jun 30, 2011 | 13.23% |
| Mar 31, 2011 | 13.49% |
| Dec 31, 2010 | 14.59% |
| Sep 30, 2010 | 15.38% |
| Dec 31, 2009 | 18.13% |
| Sep 30, 2009 | 17.81% |
| Jun 30, 2009 | 18.85% |